Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline patents new RIP-2 inhibitors

Oct. 2, 2012

Merck KGaA discloses novel agents for cancer

Oct. 2, 2012

Roche presents new antidiabetic compounds

Oct. 1, 2012

Novel BACE1 inhibitors created at Janssen Pharmaceutica

Oct. 1, 2012

New York University presents new PGRN variants for inflammation

Oct. 1, 2012

Novel AMPK activators disclosed in GSK patent

Oct. 1, 2012

Research at the University of Pennsylvania yields new cancer biotherapeutics

Oct. 1, 2012

University of Chicago designs novel anti-staphylococcal agents

Oct. 1, 2012

Array BioPharma and Genentech report novel ERK inhibitors

Sep. 28, 2012

Sanofi discloses several new agents for diabetes

Sep. 28, 2012

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...